Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement

All Live and On-Demand Activities

Filter Activities

Clear

A New Treatment Era for Light-Chain Amyloidosis:Interprofessional Lessons From a Center of Excellence

1.00 hr(s) | ABIM , CME , CPE , MOC , NCPD

Therapeutic Area(s): Cardiology , Hematology, Benign , Oncology

Release Date: July 9, 2021

Expiration Date: July 8, 2022

Location: Internet Activity Enduring

In this activity, a panel of experts discusses a team-based approach to the management of light chain (AL) amyloidosis. Hear from Suzanne Lentzsch, MD, PhD, Mathew S. Maurer, MD, and Margaret Cuomo, MSN, FNP-C, from the Columbia University Medical Center, as they give insights on diagnostic strategies for AL amyloidosis and as they explore treatment guidelines, evidence, and safety concerns of established and novel approaches to managing AL amyloidosis.

Teaming Up to Overcome Challenges in the Diagnosis and Management of Noninfectious Uveitis: Enhancing Multidisciplinary Care in the Biologic Therapy Era

1.00 hr(s) | ABO , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Noninfectious Uveitis

Therapeutic Area(s): Rheumatology

Release Date: June 28, 2021

Expiration Date: June 27, 2022

Location: Internet Activity Enduring

In this activity, experts in ophthalmology and rheumatology discuss challenges in the diagnosis and management of noninfectious uveitis.

The Spectrum of MDS: Disease Management and Patient Education

1.5 hr(s) | NCPD , Nurse Practitioners

Specialty: Myelodysplastic Syndromes

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: June 15, 2021

Expiration Date: June 14, 2022

Location: Internet Activity Enduring Material

The symposium was presented at the ONS Annual Congress virtual platform on April 29, 2021 and targeted to inpatient and outpatient clinical nursing professionals in oncology. Topics will include the latest developments in diagnosing and treating myeloid malignancies; current and emerging treatment options for low-risk MDS, high-risk MDS, and secondary AML; clinical trial participation; disease management for chronic anemia, side effects and treatment adherence; psychosocial considerations and palliative care to improve the quality of life for this patient population. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.

Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option

1.00 hr(s) | CME

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: June 21, 2021

Expiration Date: June 20, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses unmet needs of patients with moderate to severe psoriasis and the clinical potential of targeting the TYK2 pathway as a novel nonbiologic oral therapeutic option.

New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Bladder Cancer

Therapeutic Area(s): Oncology , Urologic oncology

Release Date: June 23, 2021

Expiration Date: June 22, 2022

Location: Internet Activity Enduring

In this activity, an expert in genitourinary oncology discusses new and emerging strategies for the management of patients with bladder cancer.

Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis

0.50 hr(s) | ABIM , CME , CPE , MOC , NCPD

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: June 17, 2021

Expiration Date: June 16, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses the latest evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis.

Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference

0.50 hr(s) | CME

Specialty: Hemophilia

Therapeutic Area(s): Hematology, Benign

Release Date: June 16, 2021

Expiration Date: June 15, 2022

Location: Internet Activity Enduring

In this activity, an expert in hemophilia explores the evidence supporting novel, emerging hemophilia therapeutics and provides guidance on the implications of the evidence presented for real-world practice.

1 4 5 6 7
Copy link
Powered by Social Snap